In this work, we proposed that that Dapa can diminish the occurrence and progression of DCM via ameliorating heart function and reducing oxidative stress levels through inhibiting the AT1R-FAK-NOX2 signaling pathway in the myocardial tissues. This evidence concerns the gene AGTR1 and familial dilated cardiomyopathy.